BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 26238073)

  • 1. Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
    He Y; Cui Y; Xu B; Gu J; Wang W; Luo X
    PLoS One; 2014; 9(1):e87994. PubMed ID: 24498236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC.
    Huang Y; Yu Z; Zheng M; Yang X; Huang H; Zhao L
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma.
    Jain S; Chang TT; Hamilton JP; Lin SY; Lin YJ; Evans AA; Selaru FM; Lin PW; Chen SH; Block TM; Hu CT; Song W; Meltzer SJ; Su YH
    PLoS One; 2011; 6(11):e26799. PubMed ID: 22073196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.
    Wu HC; Yang HI; Wang Q; Chen CJ; Santella RM
    Carcinogenesis; 2017 Oct; 38(10):1021-1028. PubMed ID: 28981677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF6mRNA expression in primary hepatocellular carcinoma.
    Wang S; Chen X; Zhang W; Qiu F
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):585-7. PubMed ID: 15791848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
    Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
    Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct molecular etiologies of male and female hepatocellular carcinoma.
    Natri HM; Wilson MA; Buetow KH
    BMC Cancer; 2019 Oct; 19(1):951. PubMed ID: 31615477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats.
    Tsujiuchi T; Tsutsumi M; Sasaki Y; Takahama M; Konishi Y
    Jpn J Cancer Res; 1999 Sep; 90(9):909-13. PubMed ID: 10551317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and expression of LGR6 gene in ankylosing spondylitis: A case-control study.
    Deng Y; Xu W; Ni M; Sun X; Wang X; Zhang T; Pan F
    Hum Immunol; 2023 Dec; 84(12):110719. PubMed ID: 37802707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction.
    Li K; Shi W; Song Y; Qin L; Zang C; Mei T; Li A; Song Q; Zhang Y
    Expert Rev Mol Diagn; 2023; 23(11):1015-1026. PubMed ID: 37672012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.
    Liang Y; Ma B; Jiang P; Yang HM
    Front Oncol; 2021; 11():636093. PubMed ID: 34150612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling.
    Ji W; Shi H; Shen H; Kong J; Song J; Bian H; Lv X
    Oxid Med Cell Longev; 2019; 2019():6140360. PubMed ID: 31687083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Chen S; Zhang Y; Wu X; Zhang C; Li G
    Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Hao QQ; Chen GY; Zhang JH; Sheng JH; Gao Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7496. PubMed ID: 28700498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
    Tian C; Yao S; Liu L; Ding Y; Ye Q; Dong X; Gao Y; Yang N; Li Q
    Int J Mol Med; 2017 Jan; 39(1):47-56. PubMed ID: 27909734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
    Zhou J; Lai PB; Tsui SK
    Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of PLZF in human hepatocellular carcinoma and its clinical significance.
    Hui AW; Lau HW; Cao CY; Zhou JW; Lai PB; Tsui SK
    Oncol Rep; 2015 Jan; 33(1):397-402. PubMed ID: 25369784
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.